药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02268 药明合联

未开盘 06-17 16:08:37

45.900

-0.420

-0.91%

最高46.840	最低45.460	成交量279.84万
今开46.640	昨收46.320	日振幅2.98%
总市值578.80亿	流通市值578.80亿	总股本12.61亿
成交额1.29亿	换手率0.22%	流通股本12.61亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02268","market":"HK","secType":"STK","nameCN":"药明合联","latestPrice":45.9,"timestamp":1781683717004,"preClose":46.32,"halted":0,"volume":2798431,"delay":0,"changeRate":-0.009067357512953405,"floatShares":1261000000,"shares":1261000000,"eps":1.2958520332938936,"marketStatus":"未开盘","change":-0.42,"latestTime":"06-17 16:08:37","open":46.64,"high":46.84,"low":45.46,"amount":128502402,"amplitude":0.029793,"askPrice":45.9,"askSize":3000,"bidPrice":45.82,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":1.293927922708645,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781746200000},"marketStatusCode":0,"adr":0,"listingDate":1700150400000,"exchange":"SEHK","adjPreClose":46.32,"openAndCloseTimeList":[[1781659800000,1781668800000],[1781672400000,1781683200000]],"volumeRatio":0.5292053078783978,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02268","defaultTab":"news","newsList":[{"id":"2644795877","title":"东曜药业-B(01875)与药明合联(02268)订立工艺开发及制造服务协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2644795877","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644795877?lang=zh_cn&edition=full","pubTime":"2026-06-17 06:30","pubTimestamp":1781649048,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东曜药业-B 及药明合联联合公布，2026年6月16日，东曜药业与药明生物订立工艺开发及制造服务协议，据此，东曜药业将向药明生物提供工艺开发及制造服务。东曜药业须向药明生物交付合共十批符合相关抗体试生产规格的单克隆抗体中间体。公告称，订立工艺开发及制造服务协议有助于东曜药业实现深化其技术诀窍、提升其工艺水平并巩固其交付单克隆抗体及其他生物样品工艺开发服务往绩的目标。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455265.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1141","LU2488822045.USD","02268","SG9999014674.SGD","BK1574","01875"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643822932","title":"【券商聚焦】交银国际：医药行业上半年表现整体稳健 下半年内部分化或加大","url":"https://stock-news.laohu8.com/highlight/detail?id=2643822932","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643822932?lang=zh_cn&edition=full","pubTime":"2026-06-15 10:21","pubTimestamp":1781490116,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际研报指，医药行业在1H26表现整体稳健、但内部分化也较为明显。短期关注出海交易、业绩表现和利好政策落地。推荐高景气度赛道中、投资性价比较高的头部玩家，包括药明合联、凯莱英和康龙化成。2026年港股龙头收入和净利润增速有望稳定在双位数。板块复苏积极信号已经出现。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983754","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002562.SGD","LU0320764599.SGD","09966","IE00B0JY6N72.USD","LU0181495838.USD","LU0140636845.USD","09926","01276","03329","LU3063872942.SGD","LU0819121731.USD","BK1576","02096","06821","01177","01093","02269","LU1880383366.USD","LU2399975544.HKD","LU1960683339.HKD","HK0000320264.USD","01530","00013","06160","06990","LU0456827905.SGD","02162","01548","BK1191","03692","03759","09996","IE00BZ08YR35.GBP","LU0051755006.USD","LU0737861772.HKD","LU1688375341.USD","06078","02596","LU2097828631.EUR","02268","06996","LU1242518857.USD","LU0502904849.HKD","LU0348827113.USD","01801","01952","02273","LU1226287875.USD","01951","HK0000306685.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642254781","title":"医药板块集体回升 科伦博泰生物(06990)涨7.20%、荣昌生物(09995)涨6.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642254781","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642254781?lang=zh_cn&edition=full","pubTime":"2026-06-12 13:30","pubTimestamp":1781242214,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股医药板块集体回升，科伦博泰生物 涨7.20%，荣昌生物涨6.53%，康诺亚-B涨5.58%，复宏汉霖涨5.36%，康方生物涨5.07%，君实生物涨4.61%，药明合联涨4.06%，诺诚健华涨3.96%。英伟达同时为 Abridge 投资方，新模型基于英伟达开放模型套件 Nemotron 训练，Abridge 将采用去标识化临床数据进行定制优化，预计 2026 年晚些时候上线。东莞证券研报认为，受行业合规整顿以及消费疲软等因素影响，2025年医药生物行业整体归母净利润同比有所下滑。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983673","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688331","SG9999014674.SGD","LU0417516902.SGD","LU1969619763.USD","09969","LU2476274308.USD","LU0348825331.USD","09939","LU1720050803.USD","09926","BK0239","HK0000165453.HKD","HK0000306701.USD","LU2399975544.HKD","LU1794554557.SGD","LU2488822045.USD","LU0561508036.HKD","HK0000306685.HKD","HK0000320264.USD","LU1961090484.USD","BK1583","LU0634319403.HKD","LU2328871848.SGD","06990","LU1064130708.USD","09995","LU1064131003.USD","BK1161","LU0348784397.USD","02162","LU0540923850.HKD","01877","LU0348735423.USD","BK1587","02268","HK0000320223.HKD","LU2148510915.USD","LU0348827113.USD","LU0417516571.SGD","LU0348783233.USD","BK1515","LU0417516738.SGD","LU0348767384.USD","BK1141","159938","LU0348766576.USD","LU2476274720.SGD","02696","IE00BPRC5H50.USD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101413110","title":"异动解读｜药明合联盘中下跌4.05%，回购护盘乏力股价较回购均价折价逾两成","url":"https://stock-news.laohu8.com/highlight/detail?id=1101413110","media":"行情直击","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101413110?lang=zh_cn&edition=full","pubTime":"2026-06-11 09:35","pubTimestamp":1781141738,"startTime":"0","endTime":"0","summary":"6月11日，药明合联盘中下跌4.05%，报45.2港元/股，成交额1686.73万港元，股价较此前回购均价57.3港元已折价逾21%，跌势进一步加深。消息面上，公司此前披露专业受托人以均价57.3港元回购570.2万股，总代价约3.27亿港元，母公司药明生物亦有不超过4亿美元回购计划，药明系合计回购规模达5亿美元。然而密集回购仍未能有效扭转抛压，药明合联已连续多个交易日走弱，市场情绪持续低迷。行业内今日表现分化，药明生物跌0.94%，药明康德涨0.58%，金斯瑞生物科技涨1.37%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196892052","title":"异动解读｜药明合联盘中下跌3.59%，回购护盘乏力药明系板块持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1196892052","media":"行情直击","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196892052?lang=zh_cn&edition=full","pubTime":"2026-06-09 09:47","pubTimestamp":1780969674,"startTime":"0","endTime":"0","summary":"6月9日，药明合联盘中下跌3.59%，报45.1港元/股，成交额4365.82万港元，股价较此前回购均价57.3港元已折价逾21%，跌势进一步加深。消息面上，公司此前披露专业受托人以均价57.3港元回购570.2万股，总代价约3.27亿港元，母公司药明生物亦有不超过4亿美元回购计划，药明系合计回购规模达5亿美元。然而密集回购仍未能有效扭转抛压，今日板块全线走弱，药明生物跌4.81%、药明康德跌4.86%、金斯瑞生物科技跌3.97%，生命科学工具和服务板块整体承压明显。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139909827","title":"异动解读｜药明合联盘中下跌3.73%，密集回购难挡抛压药明系板块持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1139909827","media":"行情直击","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139909827?lang=zh_cn&edition=full","pubTime":"2026-06-08 10:09","pubTimestamp":1780884559,"startTime":"0","endTime":"0","summary":"6月8日，药明合联盘中下跌3.73%，报48.2港元/股，成交额7898.48万港元，较此前回购均价57.3港元已折价逾15%，股价跌势持续加深。然而密集回购仍未能有效扭转抛压，今日板块全线走弱，药明生物跌6.17%、药明康德跌3.13%、金斯瑞生物科技跌4.72%，生命科学工具和服务板块整体承压明显。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179688887","title":"药明合联发布5月股份变动月报表，总股本增至1,261,307,505股","url":"https://stock-news.laohu8.com/highlight/detail?id=1179688887","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179688887?lang=zh_cn&edition=full","pubTime":"2026-06-04 16:37","pubTimestamp":1780562241,"startTime":"0","endTime":"0","summary":"药明合联于2026年6月4日公布2026年5月股份变动月报。公告显示，公司于本月并无法定/注册股本变动，法定/注册股本仍为10,000,000,000股普通股，每股面值0.00005美元，总额500,000美元。本月普通股从上月底的1,260,609,335股增加至1,261,307,505股，新增698,170股，均来自多项首次公开发售前购股权计划的行使。根据公告披露，此次行使期权所得资金合计为人民币1,300,820.92元。公司同时确认当月无股票回购、注销或库藏股变动事项。截至2026年5月末，公司已发行股份总数为1,261,307,505股，库存股份数为0股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640973917","title":"港股午评：恒指跌1.69% 科指跌2.35% 科网股普跌 光通信板块逆势上涨 美团跌超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640973917","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640973917?lang=zh_cn&edition=full","pubTime":"2026-06-03 11:51","pubTimestamp":1780458660,"startTime":"0","endTime":"0","summary":"　　6月3日消息，港股三大指数集体下跌。截至午间收盘，恒生指数跌1.69%，报25599.02，恒生科技指数跌2.35%，国企指数跌2.1%。盘面上，科网股普跌，美团跌超6%，快手跌超5%，哔哩哔哩跌超4%，京东、腾讯、小米跌超3%；光通信板块逆势上涨，长飞光纤光缆涨超16%；新消费概念股回调，蜜雪集团跌超5%；创新药概念股走弱，药明合联跌超5%。此外，海外龙头映射提振情绪：隔夜美股市场，光通信芯片巨头迈威尔科技 股价飙升超32%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-06-03/doc-iniacaet0967936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2097828557.USD","BK4614","LU2242649171.HKD","LU1993786604.SGD","2NVD.UK","LU0588545730.USD","LU0289739343.SGD","LU0109391861.USD","LU1242518931.SGD","LU0651946864.USD","LU2487616109.SGD","LU2106854487.HKD","LU1951186391.HKD","IE0008368411.USD","LU0348816934.USD","LU0342679015.USD","LU0593848301.USD","LU0823040885.USD","LU0463099449.HKD","LU0557290698.USD","IE00BMPRXN33.USD","LU1169590202.USD","LU2257852520.SGD","LU0577902298.EUR","LU0985320562.USD","LU0315178854.USD","IE00BN29S564.USD","LU1733274473.HKD","LU1861127337.USD","LU2750360641.GBP","IE00BQXX3D17.EUR","LU1831875114.USD","06869","IE00B031HW06.USD","LU0192582467.USD","BK1141","IE0008368742.USD","IE0034224299.USD","LU0251132253.USD","LU0823414478.USD","LU2326559502.SGD","BK4592","LU0203202063.USD","LU0543330483.HKD","LU0228659784.USD","LU1226288170.HKD","LU1674673428.USD","LU0882574139.USD","LU2092937148.SGD","IE00BZ1G4Q59.USD","LU0259732245.USD","LU2168564149.EUR","LU0588545904.SGD","LU2097828631.EUR","LU1119994496.HKD","LU0326948709.USD","IE0034235188.USD","LU0828238088.HKD","LU0880133367.SGD","LU2999663052.SGD","LU0289960550.SGD","LU2213496289.HKD","LU0234572021.USD","LU0210528500.USD","IE00B067MR52.USD","IE00B5MMRT66.SGD","02833","LU1282649141.HKD","LU0898667661.SGD","LU2322448791.USD","BK4581","LU0862451753.SGD","LU2051468812.USD","LU1791710400.SGD","IE00B1XK9C88.USD","LU1989772923.USD","IE0003851619.USD","BK1609","LU2272731865.HKD","LU1712237335.SGD","IE00B775H168.HKD","LU0444971666.USD","HTCD.SI","LU1196710195.USD","LU0039217434.USD","LU2065171311.SGD","LU0157215616.USD","SG9999002562.SGD","LU1251922891.USD","LU2491050071.SGD","IE0003U64NQ7.SGD","SG9999014542.SGD","BK1095","IE000KEQY171.SGD","LU0029875118.USD","LU0588545490.SGD","LU1046422090.SGD","LU0043850808.USD","LU0329678337.USD","IE00BK4W5L77.USD","LU0577902611.USD","LU1282651121.HKD","LU0169518387.USD","LU1645745479.HKD","NVDB","LU0310800379.SGD","LU0175139822.USD","LU0873338254.USD","LU2125910500.SGD","NVDO","LU1699723380.USD","IE000ITXATA3.USD","IE00B3S45H60.SGD","03067","SG9999014898.SGD","HK0000352291.HKD","LU1064131342.USD","LU1642822792.SGD","LU2290526834.HKD","LU2462157665.USD","IE0032834883.USD","LU0384037296.USD","LU0164865239.USD","LU2125909247.SGD","LU2756315318.SGD","LU2250418816.HKD","LU1880383366.USD","SG9999006514.SGD","LU1785774172.SGD","BK1531","LU1037948541.HKD","LU0173614495.USD","IE00BFSS7M15.SGD","LU0708995401.HKD","LU2148611432.USD","NVDU","IE00BQXX3F31.USD","LU1196710864.SGD","LU1815336760.USD","LU0577902371.SGD","LU2148510915.USD","IE00BZ08YT58.USD","LU1048484197.HKD","LU0210536198.USD","LU1316542783.SGD","LU2543165471.USD","LU2125909759.SGD","SG9999015952.SGD","SG9999014559.SGD","BK4550","IE00BHPRN162.USD","LU0080751232.USD","LU0164872284.USD","LU1688375341.USD","LU2463028550.USD","LU2491049909.HKD","NVDS.UK","LU0348767384.USD","BK1506","LU0640798160.USD","LU2023251221.USD","HK0000532082.HKD","LU0607220059.USD","LU1267930490.SGD","LU0054450605.USD","BK4141","LU1116320901.HKD","LU0231483743.USD","NVYY","LU2097344357.USD","BK1521","LU0889565833.HKD","LU0320764599.SGD","LU0572944931.SGD","LU2065170008.USD","LU0269904917.USD","LU1267930573.SGD","LU0143863784.USD","LU0531971595.HKD","LU0235996351.USD","IE00BD6J9T35.USD","LU0417517546.SGD","LU2100268510.USD","LU0165289439.USD","LU2931357623.SGD","BK1249","LU1934455194.USD","LU2896262040.SGD","LU0589944569.HKD","MCHmain","LU1868836757.USD","LU1400636574.HKD","NVDY","SG9999004303.SGD","LU1066051811.HKD","LU1815333072.USD","LU2237438978.USD","LU0048584097.USD","IE0004091025.USD","IE00BBT3K403.USD","LU0048388663.USD","LU0871576103.HKD","LU0823434740.USD","LU2362540622.SGD","LU0633140560.USD","IE00BKDWB100.SGD","LU2399975544.HKD","LU1102505762.USD","LU1989764748.USD","IE0009570106.USD","LU0531970944.HKD","LU1267930730.SGD","LU1794554557.SGD","LU0238689110.USD","LU2251237306.USD","LU1769817179.HKD","LU1823568750.SGD","LU1515016050.SGD","BK4551","SG9999014914.USD","LU0724617625.USD","IE00B0JY6N72.USD","IE00BWXC8680.SGD","LU0323591593.USD","LU1152091168.USD","LU0965509101.SGD","LU0964807845.USD","LU0886674414.USD","LU1548497426.USD","LU2413666426.HKD","LU0516422952.EUR","LU2125910849.SGD","IE000W1ABFV2.USD","LU2452424414.USD","02837","MIUmain","LU1868838027.USD","LU0097036916.USD","LU2756315664.SGD","LU2357305700.SGD","07300","IE00B775SV38.USD","LU1923622291.USD","LU1145028129.USD","LU1808992512.USD","03032","LU0823414551.USD","LU2430703251.USD","LU0543330566.HKD","MRVU","LU1226288097.SGD","LU1551013425.SGD","LU0109392836.USD","IE0032431581.USD","HK0000306685.HKD","03037","LU2237443622.USD","07226","BK1607","LU1770034418.SGD","LU0675040207.SGD","LU0689472784.USD","LU1989772840.SGD","IE00BQXX3C00.GBP","83115","LU0320764243.SGD","LU2008162690.USD","LU0700851271.USD","LU0124676726.USD","LU1153585028.USD","BK4579","LU0577902454.USD","LU1960683339.HKD","LU0821914370.USD","LU1226287529.USD","LU0823413660.USD","LU1226287792.SGD","LU2177674079.SGD","LU0449509016.USD","LU0029864427.USD","SG9999001903.USD","LU2362541273.HKD","LU0256863902.USD","HK0000304805.HKD","LU0228367735.SGD","LU0072913022.USD","LU0067412154.USD","LU0289961442.SGD","LU0345776255.USD","LU1328277881.USD","01810","LU0154236417.USD","SG9999013353.USD","LU0077335932.USD","LU2089283258.USD","BK1516","LU0132412106.USD","NVDD","LU1323998911.USD","BK4605","LU0326950275.SGD","BILI","LU0577902538.SGD","LU0878004406.USD","LU0323240290.USD","LU1981816686.USD","LU2456880835.USD","LU2420271590.USD","MRVL","LU2237957902.USD","LU1551013342.USD","LU1064130708.USD","LU2125909593.SGD","LU1778281490.HKD","LU0348825331.USD","LU1839511570.USD","LU2272731600.USD","IE00BYXW3230.USD","03423","LU0417516902.SGD","LU0943347566.SGD","LU1429558221.USD","LU0158827948.USD","LU1211504680.USD","SG9999000327.SGD","LU1568876335.HKD","LU0048597586.USD","LU0261950983.USD","LU0345775950.USD","LU0266013472.USD","SG9999001226.SGD","HK0000320264.USD","LU2097828805.USD","07500","07552","LU2462591350.SGD","LU0414403682.SGD","LU2506951792.HKD","HK0000320223.HKD","LU0328353924.USD","LU0417516738.SGD","NVDQ","LU0323239441.USD","LU1069344957.HKD","IE00BK4W5M84.HKD","LU0890818403.SGD","LU1169589451.USD","LU2125909916.SGD","LU1868837136.USD","LU0128525929.USD","LU2361045086.USD","LU0390134368.USD","LU1914381329.SGD","LU2097828714.EUR","IE0009356076.USD","LU0359201885.HKD","LU1115378108.SGD","NVD","LU0455707207.USD","LU0942090050.USD","IE00B0169L03.USD","LU0572939691.SGD","LU2089284900.SGD","LU0274383776.USD","LU1770036033.HKD","LU0188438112.USD","LU0348805143.USD","07388","LU1102505929.USD","SG9999003461.SGD","LU0865486749.SGD","LU1046421795.USD","LU1366334651.USD","LU1804176565.USD","LU1051769294.HKD","BK4527","IE00B97KM107.HKD","LU0823041008.USD","LU1935042488.USD","SG9999015358.SGD","LU0215105999.USD","LU0608807433.USD","LU0683595622.HKD","LU0861579265.USD","NVDW","LU0561508036.HKD","LU1023057109.AUD","LU0049853897.USD","HK0000819398.USD","LU0456842615.SGD","LU0672654166.SGD","NVIW.SI","LU0823038988.USD","LU1496350502.SGD","LU1642822529.SGD","LU2317271919.USD","NVDS","HXXD.SI","IE00B3SWFQ91.USD","LU0211328371.USD","LU0494093205.USD","03033","LU0738912210.USD","LU0056508442.USD","IE00BGV7N243.SGD","LU2491050154.USD","LU1048588211.SGD","LU0345769631.USD","IE00B543WZ88.USD","LU0502904849.HKD","LU2264538146.SGD","IE00BMPRXR70.SGD","LU0353189763.USD","MPNGY","BK4548","LU1814569148.SGD","LU0006306889.USD","IE00B19Z9505.USD","LU0683600562.USD","LU0276348264.USD","LU1366192091.USD","LU1481107354.HKD","LU0862451837.USD","09067","LU2097344431.USD","LU2152927971.USD","LU1044876610.USD","LU0081259029.USD","BK4515","LU0823039010.USD","IE0004086264.USD","LU2637965513.SGD","LU1691799644.USD","SG9999000459.SGD","LU0310799852.SGD","LU2279701549.SGD","LU2211815571.USD","BK1608","TCEHY","LU0348814723.USD","LU1226287875.USD","LU0051755006.USD","81810","IE0034235303.USD","IE00B19Z8X17.USD","LU1571399168.USD","LU1105468828.SGD","LU1721428933.USD","LU1988902786.USD","LU2417539215.USD","LU2954938101.SGD","LU1037948897.HKD","LU0061477393.USD","LU1720051108.HKD","LU1951198990.SGD","LU0476273544.USD","LU2403377893.USD","LU1734074674.USD","LU2461242641.AUD","LU0149534421.HKD","LU0196878994.USD","LU2098885051.SGD","BK4608","LU2462611646.USD","SG9999014906.USD","IE00B4JS1V06.HKD","LU0868494617.USD","LU1400636657.SGD","SG9999015945.SGD","LU2108987350.USD","LU0345768153.USD","LU1400636491.USD","IE00BMPRXQ63.HKD","LU1084165304.USD","LU2458330243.SGD","BK1586","LU1733274390.USD","LU2247934214.USD","IE00BJLML261.HKD","LU2476274720.SGD","HK0001040143.USD","LU2488822045.USD","LU0096364046.USD","LU0348783662.USD","LU0594300179.USD","LU1127390331.HKD","LU2471134796.USD","LU1629891620.HKD","LU1868837300.USD","LU0608807946.USD","02268","LU0348735423.USD","LU0965509010.AUD","LU0029874905.USD","LU0049112450.USD","LU1064131003.USD","LU0788109477.HKD","LU0737861699.HKD","LU0267386448.USD","LU0784639295.USD","LU1769817096.USD","LU2360032135.SGD","LU1868837722.USD","01024","LU1629966141.USD","LU0469268626.HKD","BK4549","LU0348766576.USD","LU0057025933.USD","BK1588","NVII","HK0000165453.HKD","LU2237443382.USD","LU1044874839.SGD","LU0348827113.USD","LU0359202008.SGD","LU0315179316.USD","LU0354030438.USD","BK1610","IE00B031J352.USD","KSTmain","LU0831103253.SGD","LU0541502299.USD","LU0516422440.USD","09626","LU1282649810.SGD","IE00B29SXG58.USD","NVDX","LU0345768740.USD","SG9999015978.USD","LU0359201612.USD","LU1224709979.USD","LU2237443895.HKD","LU1791710582.SGD","00700","BK1618","NVDL","LU2047632596.USD","LU0256863811.USD","LU1917777945.USD","82800","SG9999007991.SGD","LU0441854154.USD","LU1655091459.SGD","LU0689626769.HKD","LU0287142896.SGD","LU3102509885.SGD","LU1861220033.SGD","SGXZ99366536.SGD","LU1934455863.HKD","SGXZ23171101.USD","LU0737861772.HKD","BK4598","513600","BK1591","BK4587","LU0819121731.USD","LU0516423091.SGD","LU2458330169.SGD","NVD2.UK","LU0501845795.SGD","LU0158827781.USD","LU0187121727.USD","LU2361044865.SGD","MVLL","SG9999014880.SGD","LU2471134879.HKD","LU0708995153.HKD","LU1188198961.HKD","SG9999014575.USD","HSTECH","BK1149","LU1935043536.SGD","LU1152091754.HKD","IE00BLSP4452.SGD","SG9999018857.SGD","LU0210527791.USD","BK1583","LU0528227936.USD","SG9999006597.SGD","LU0965509283.SGD","LU1439103000.SGD","IE0004445239.USD","LU0348784397.USD","LU0316494557.USD","LU2505996681.GBP","TCHmain","LU0143551892.USD","LU0823434583.USD","LU0052750758.USD","IE00BN8TJ469.HKD","BK4532","NVDG","LU1048596156.SGD","LU1989764664.SGD","IE00BKPKM429.USD","LU0264606111.USD","LU2552382132.HKD","LU1992135399.USD","LU1303367103.USD","LU1810669033.SGD","601869","LU1674673691.USD","LU0061475181.USD","LU2063271972.USD","HK0000306701.USD","LU1235294995.USD","LU2097828474.EUR","IE0005OL40V9.USD","LU0079474960.USD","LU0106261372.USD","HK0000304797.USD","LU2778985437.USD","LU2498475776.HKD","LU1066053197.SGD","BK1615","LU2023250504.SGD","LU0320765059.SGD","LU0828237510.HKD","LU0094547139.USD","SG9999001424.SGD","LU0444973449.USD","IE00B8HQ1Z84.USD","LU0651947912.USD","LU1633808545.USD","LU0293314216.USD","LU2361044949.HKD","IE00BZ08YS42.EUR","LU0261947096.USD","IE0003795394.USD","LU1807302812.USD","LU1861215975.USD","LU0820561818.USD","LU0011850046.USD","07788","BK1517","IE0008369823.USD","IE00BJJMRX11.SGD","LU2039709279.SGD","LU1202635105.USD","LU0164880469.USD","LU2602419157.SGD","SG9999015986.USD","IE00B7KXQ091.USD","LU0070217475.USD","LU2552382058.USD","LU0229945570.USD","LU0370786039.SGD","LU1935042215.USD","JD","BK1523","LU0163747925.USD","LU0640476718.USD","LU1226288253.USD","LU0511384066.AUD","SG9999017495.SGD","LU0431992006.USD","LU2272731782.SGD","LU1328615791.USD","LU0251144936.SGD","LU0856984785.SGD","LU0203347892.USD","LU0327786744.USD","BK4534","LU0594300419.USD","LU0672654240.SGD","LU0823421333.USD","LU0345770308.USD","LU0823426480.USD","BK4543","LU0082616367.USD","LU0786609619.USD","LU0211331839.USD","BK1590","BK1104","BK1619","LU0225283273.USD","LU1232071149.USD","LU1623119135.USD","LU2242650005.HKD","LU2746668461.USD","LU1504937902.USD","LU0957791311.USD","LU0488056044.USD","LU0054237671.USD","BK1526","IE00BPRC5H50.USD","IE00BF5LJ272.USD","IE00BDCRKT87.USD","LU0347712357.USD","LU0823426308.USD","HK0000286598.CNH","IE00BLSP4239.USD","LU2045819591.USD","LU2357125470.USD","BK4503","LU2394011477.USD","IE00B1BXHZ80.USD","LU0791590937.USD","LU2413666699.HKD","LU0265550946.USD","SGXZ51526630.SGD","BK1575","LU1852331112.SGD","LU0456827905.SGD","LU1992135472.HKD","IE00B5949003.HKD","LU0979878070.USD","SG9999001051.SGD","81024","SGXZ90724238.SGD","LU2381873111.SGD","LU2089985449.USD","LU0516422366.SGD","LU2244417387.USD","LU0797268264.HKD","LU2237443465.HKD","LU0117841782.USD","LU0823397103.USD","LU1282648689.USD","LU0047713382.USD","LU1366333091.USD","LU0308772762.SGD","LU2271345857.HKD","LU0069063385.USD","GB00BDT5M118.USD","LU0210533765.USD","LU0820561909.HKD","LU0072462343.USD","LU1868836914.USD","LU2430703095.HKD","HK0000914660.USD","LU0307460666.USD","BK1193","LU1883866441.USD","SG9999015341.SGD","LU0648948544.HKD","BK4585","LU0605514214.HKD","BK1604","LU0708995583.HKD","LU2293587155.HKD","LU2592432038.USD","IE00B0169N27.USD","09618","LU0140636845.USD","LU0719512351.SGD","IE00B031HY20.USD","LU0084288322.USD","LU1956131251.USD","LU2471134523.USD","LU2552382215.SGD","BK1589","LU2746668974.SGD","03419","IE0009G5SDU7.USD","LU2265009873.SGD","SG9999001069.SGD","BK1142","LU0819123356.HKD","LU2294711713.HKD","03417","LU0061474960.USD","NVD3.UK","LU2023250330.USD","LU2294711473.HKD","LU2168564065.EUR","LU0456846285.SGD","LU1720050803.USD","IE0004445015.USD","LU0918141705.HKD","LU0117844026.USD","LU1813983027.USD","BK1587","SG9999001689.USD","LU0345769128.USD","LU1568876251.USD","BK4588","LU3063872942.SGD","IE00BFSS8Q28.SGD","LU1868836591.USD","LU2083900584.USD","LU1923622614.USD","LU1323610961.USD","SGXZ31699556.SGD","LU0823413587.USD","LU0650527681.SGD","LU0965508806.USD","LU1720051017.SGD","LU0354030511.USD","LU0611395673.USD","LU0882747503.HKD","LU0449515922.USD","SG9999018865.SGD","LU1675838814.USD","LU2476274308.USD","HK0000151867.HKD","LU0499858602.USD","89618","LU0106259558.USD","LU0011963245.USD","LU1725190679.HKD","LU1821325948.USD","LU2092627202.USD","IE00BJTD4V19.USD","LU0127658192.USD","LU2249611893.SGD","LU0868494708.USD","LU2087589342.USD","LU0820562030.AUD","LU1935043023.USD","LU1051768304.USD","HSI","BK4604","03690","LU0540923850.HKD","LU0708994859.HKD","LU1303224171.USD","LU1244550221.USD","SG9999002463.SGD","LU1974910355.USD","LU1803068979.SGD","LU1719994722.HKD","LU0396098781.USD","BK4567","IE00BZ08YR35.GBP","LU0244354667.USD","LU0868486357.SGD","IE00BJJMRY28.SGD","LU2360107168.USD","LU0214875030.USD","LU0348788117.USD","LU1718418525.SGD","SG9999002224.SGD","LU0265550359.USD","LU1439102457.SGD","NVDA","LU0106252389.USD","LU2505996509.AUD","LU0096374516.USD","SNVD.UK","LU1261432733.SGD","03115","HK0001040168.HKD","LU0072462426.USD","LU1196710351.USD","LU2168564495.EUR","LU1366334578.USD","IE00BDRTCR15.USD","LU1066051225.USD","LU0972618739.USD","LU2077746001.SGD","LU2111349929.HKD","LU1224444064.USD","LU0572940350.SGD","LU1435385759.SGD","LU2449936058.SGD","LU1244550577.SGD","SG9999004220.SGD","LU0466842654.USD","LU0096362180.USD","LU1934455277.USD","LU1961090484.USD","IE00BZ199S13.USD","LU2065169927.USD","IE000YTNTUN2.SGD","SG9999014567.USD","LU0345770993.USD","LU0787776722.HKD","LU2226246903.HKD","LU0957808578.USD","LU0417516571.SGD","LU2360106780.USD","SG9999014674.SGD","LU1280957306.USD","LU1244550494.USD","LU0828237940.HKD","LU2065171402.SGD","IE00B19Z8W00.USD","LU0053666078.USD","LU2191332357.HKD","LU2125154778.USD","LU2237957811.SGD","LU2471134952.CNY","LU0320764755.SGD","LU0823421416.USD","BK4529","LU0048580855.USD","LU0234570918.USD","SGXZ81514606.USD","LU2237443549.SGD","LU0133085943.USD","LU1242518857.USD","LU1008478684.HKD","LU2028103732.USD","LU1868837565.USD","LU2860962120.EUR","SG9999000418.SGD","LU0918141887.USD","LU0203201768.USD","LU0823397285.USD","LU0211977185.USD","IE00BJTD4N35.SGD","SG9999002232.USD","LU0254981946.USD","IE0003895053.USD","LU0128522157.USD","LU1923623000.USD","HK0000914686.HKD","LU0061474705.USD","LU2251237488.HKD","LU0516423174.USD","BK4533","XIACY","LU1880383440.USD","LU0348723411.USD","BK4554","IE0034235295.USD","LU1044875133.USD","LU2473716301.USD","LU0348783233.USD","LU0509642566.USD","LU0353189680.USD","LU2087625088.SGD","LU0314109678.HKD","LU1951200564.SGD","3NVD.UK","LU0633140727.USD","HMTD.SI","IE0001KFT4U8.USD","LU2433249047.HKD","ANV","09115","LU0149721374.USD","LU1935042991.SGD","LU0128522744.USD","LU0181495838.USD","02800","IE00B4YYXB79.USD","BK4612","LU0170899867.USD","LU2236285917.USD","LU0541501648.USD","LU0634319403.HKD","IE00B8L5B284.USD","LU0174119429.USD","BK1233","LU0499858438.USD","LU1116320737.USD","LU2087621335.USD","LU2286300806.USD","DIPS","LU0203345920.USD","LU1496350171.SGD","LU2462591277.SGD","LU2750360997.AUD","LU0106959298.USD","LU0878005551.USD","SG9999002828.SGD","LU1282651048.USD","LU2237443978.SGD","09088","LU2362541513.USD","LU2133065610.SGD","LU2242644610.SGD","LU2054465674.USD","HHImain","BK1502","LU0211327993.USD","IE00BKVL7J92.USD","LU0107464264.USD","IE00B3M56506.USD","LU1282649067.USD","LU2168563687.JPY","LU0588546209.SGD","LU0143863198.USD","LU0198837287.USD","LU0472753341.HKD","LU0791591158.USD","IE0031814852.USD","07200","LU0329678170.USD","LU0642271901.SGD","LU1035775433.USD","LU2430703178.SGD","LU0210526637.USD","SG9999001093.SGD","LU2322448957.HKD","HK0000352382.USD","LU1235295612.USD","03088","LU2125154935.USD","LU2168564222.USD","LU1066051498.USD","SG9999001846.SGD","LU1983260115.SGD","LU1670756490.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143877447","title":"异动解读｜药明合联盘中下跌3.01%，回购提振短暂药明系板块再度承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1143877447","media":"行情直击","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143877447?lang=zh_cn&edition=full","pubTime":"2026-06-03 09:54","pubTimestamp":1780451643,"startTime":"0","endTime":"0","summary":"6月3日，药明合联盘中下跌3.01%，报53.1港元/股，成交额3077.8万港元，此前反弹仅维持两个交易日便再度走弱。消息面上，公司此前披露专业受托人于5月19日至29日期间以均价57.3港元回购570.2万股，总代价约3.27亿港元；同时公司公告拟于股东周年大会审议授权回购不超过已发行股本10%的股份。母公司药明生物亦有不超过4亿美元回购计划，药明系合计回购规模达5亿美元。然而密集回购仍未能有效扭转抛压，今日板块内药明生物跌4.55%、药明康德跌2.0%，药明系整体承压明显。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161216170","title":"药明合联拟回购不超过已发行股本10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1161216170","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161216170?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:57","pubTimestamp":1780304272,"startTime":"0","endTime":"0","summary":"2026年6月1日，药明合联在港交所发布公告称，公司拟于2026年6月26日召开股东周年大会，审议并授权董事在一定期间内于香港联合交易所有限公司或满足相关法规及上市规则要求的其他交易场所回购股份规模不超过公司已发行股本总数的10%，即不超过126,130,750股。公告显示，截至2026年5月29日，药明合联的已发行股份总数为1,261,307,505股，上述回购股份可能根据市场状况以及资本管理需要被公司注销或以库存股份形式持有。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药明合联拟回购不超过已发行股本10%股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137136681","title":"异动解读｜药明合联盘中上涨3.1%，回购落地叠加板块回暖提振情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1137136681","media":"行情直击","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137136681?lang=zh_cn&edition=full","pubTime":"2026-06-01 09:51","pubTimestamp":1780278711,"startTime":"0","endTime":"0","summary":"6月1日，药明合联盘中上涨3.1%，报55.6港元/股，成交额4129.77万港元，延续此前反弹走势。消息面上，公司此前披露专业受托人于5月19日至29日期间在公开市场购买570.2万股，总代价约3.27亿港元，平均购买价每股57.3港元，资金全部来自公司自有财务资源。叠加母公司药明生物不超过4亿美元回购计划，药明系合计回购规模达5亿美元。国泰海通维持公司\"增持\"评级，目标价84.38港元，看好ADC赛道增长前景。板块内药明生物今日涨5.94%，整体情绪明显回暖。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0f11b49b14caa7db2a23dca79e92d41a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102753792","title":"异动解读｜药明合联盘中上涨3.22%，受托人斥资3.27亿港元回购570万股提振信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1102753792","media":"行情直击","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102753792?lang=zh_cn&edition=full","pubTime":"2026-05-29 09:43","pubTimestamp":1780019003,"startTime":"0","endTime":"0","summary":"5月29日，药明合联盘中上涨3.22%，报53.75港元/股，成交额3277.35万港元，此前连续多个交易日走弱后出现反弹。消息面上，公司当日公告披露，专业受托人于5月19日至29日期间在公开市场购买570.2万股股份，占已发行股份总数约0.45%，总代价约3.27亿港元，平均购买价每股57.3港元，资金全部来自公司自有财务资源。此外，母公司药明生物此前宣布不超过4亿美元回购计划，药明系合计回购规模达5亿美元。板块内药明康德涨4.3%、药明生物涨2.29%，整体情绪回暖。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639614545","title":"药明合联(02268)：专业受托人于公开市场上购买570.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2639614545","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639614545?lang=zh_cn&edition=full","pubTime":"2026-05-29 06:37","pubTimestamp":1780007830,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明合联(02268)发布公告，于2026年5月19日至2026年5月29日期间，专业受托人在公开市场上购买570.2万股股份(相当于本公告日期已发行股份总数约0.45%)，总代价约为3.27亿港元，平均购买价为每股57.3港元。股份购买的资金全数由本公司的自有财务资源拨付。所购买股份目前由受托人根据本公司股份计划的规则以及本公司与受托人订立的信托契约条款持有。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447477.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","SG9999014674.SGD","02268","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183789229","title":"药明合联受托人斥资3.265亿港元，于5月19日至29日期间以均价57.3港元回购570万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1183789229","media":"美股速递","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183789229?lang=zh_cn&edition=full","pubTime":"2026-05-29 06:32","pubTimestamp":1780007536,"startTime":"0","endTime":"0","summary":"药明合联的受托人于2026年5月19日至29日期间，在公开市场进行了一系列股份回购。数据显示，此次回购行动共涉及570万股股份，总耗资约3.265亿港元。经计算，平均每股回购价格约为57.3港元。这一举措通常被视为公司对自身未来发展抱有信心的信号，也可能旨在提升股东价值或优化资本结构。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","02268","SG9999014674.SGD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638663070","title":"港股收评：恒指跌1.27%险守25000点 科指跌0.39% 科网股低迷 黄金股普跌 智谱逆势涨超13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638663070","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638663070?lang=zh_cn&edition=full","pubTime":"2026-05-28 16:08","pubTimestamp":1779955680,"startTime":"0","endTime":"0","summary":"　　5月28日消息，港股三大指数集体下跌。截至收盘，恒生指数跌1.27%，报25006.16，恒生科技指数跌0.39%，国企指数跌1.17%。盘面上，科网股跌多涨少，美团跌超5%，阿里巴巴、腾讯、哔哩哔哩、百度跌超2%，联想涨超3%；黄金股普跌，中国黄金国际跌超6%；创新药概念股持续走弱，药明合联跌超7%；AI应用股部分上涨，智谱涨超13%。　　AI应用股部分上涨，智谱涨超13%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"bda70603471d4704b927f5f6be770320","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-05-28/doc-inhzmtwq8653089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["07552","03115","SG9999001093.SGD","09088","03088","HSTECH","07226","02099","513600","03032","02800","83115","SG9999003461.SGD","SG9999014674.SGD","03419","09115","09067","02833","02513","HSI","07300","82800","03423","BK1198","BK1592","LU2488822045.USD","02837","07500","03033","BK1544","HHImain","03417","BK1117","02268","07200","MCHmain","03067","JINFF","BK1141","03037"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187958849","title":"异动解读｜药明合联盘中下跌3.14%，密集回购未能扭转板块持续抛压","url":"https://stock-news.laohu8.com/highlight/detail?id=1187958849","media":"行情直击","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187958849?lang=zh_cn&edition=full","pubTime":"2026-05-28 09:46","pubTimestamp":1779932784,"startTime":"0","endTime":"0","summary":"5月28日，药明合联盘中下跌3.14%，报55.4港元/股，成交额2810.37万港元，连续多个交易日走弱。消息面上，公司此前公告拟动用最多1亿美元内部资金在公开市场回购股份，母公司药明生物亦宣布不超过4亿美元回购计划，合计回购规模达5亿美元。然而密集回购仍未能有效提振市场信心，药明系个股整体承压，药明康德跌3.52%、药明生物跌2.73%。国泰海通维持公司\"增持\"评级，目标价84.38港元，看好ADC赛道增长前景。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110755377","title":"异动解读｜药明合联盘中下跌3.04%，回购利好未能抵消板块持续抛压","url":"https://stock-news.laohu8.com/highlight/detail?id=1110755377","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110755377?lang=zh_cn&edition=full","pubTime":"2026-05-27 10:58","pubTimestamp":1779850685,"startTime":"0","endTime":"0","summary":"5月27日，药明合联盘中下跌3.04%，报55.75港元/股，成交额8616.81万港元。消息面上，公司此前公告拟动用最多1亿美元内部资金在公开市场回购股份，母公司药明生物亦于5月26日宣布不超过4亿美元的回购计划，合计回购规模达5亿美元。然而密集回购未能有效提振股价，板块整体承压明显。生命科学工具和服务行业中，药明生物跌1.22%、药明康德跌1.55%、晶泰控股跌3.11%。国泰海通维持公司\"增持\"评级，目标价84.38港元，看好ADC赛道增长前景。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638001595","title":"【券商聚焦】国泰海通维持药明合联(02268)“增持”评级 指其回购彰显长期信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2638001595","media":"金吾财讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638001595?lang=zh_cn&edition=full","pubTime":"2026-05-26 14:41","pubTimestamp":1779777692,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国泰海通证券发布研报指，药明合联 拟使用最高1亿美元内部资金开展股份回购，彰显长期发展信心。公司现金储备充裕，为资本开支提供坚实基础。国泰海通看好ADC等新模态药物带动下对CDMO需求的提升及公司业绩的持续兑现，维持“增持”评级，目标价84.38港元。2025年，在金额超过10亿美元的ADC并购交易中，50%的被收购方是药明合联客户。未完成订单约14.89亿美元，同比增长50.3%；新签合同价值13.3亿美元，同比增长41%。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1982186","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02611","02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153962782","title":"异动解读｜药明合联盘中下跌3.14%，报56.05港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1153962782","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153962782?lang=zh_cn&edition=full","pubTime":"2026-05-26 10:09","pubTimestamp":1779761383,"startTime":"0","endTime":"0","summary":"5月26日，药明合联盘中下跌3.14%，报56.05港元/股，成交额6748.74万港元。药明合联所在的生命科学工具和服务行业中，个股表现分化，其中药明生物涨3.73%，金斯瑞生物科技涨0.08%，药明康德跌2.0%，晶泰控股跌2.39%，英矽智能跌3.77%。药明合联生物技术有限公司是一家主要从事提供抗体偶联药物（ADC）及其他生物偶联药物的全面合同研究、开发及制造组织（CRDMO）服务的投资控股公司，业务覆盖国内市场、北美、欧洲和世界其他地区。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175372022","title":"异动解读｜药明合联盘中下跌3.03%，报55.95港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175372022","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175372022?lang=zh_cn&edition=full","pubTime":"2026-05-21 15:36","pubTimestamp":1779348968,"startTime":"0","endTime":"0","summary":"5月21日，药明合联盘中下跌3.03%，报55.95港元/股，成交额1.48亿港元。药明合联所在的生命科学工具和服务行业中，个股表现分化，其中昭衍新药涨6.06%，药明康德涨1.62%，晶泰控股涨0.76%，药明生物跌1.03%，英矽智能跌4.78%。药明合联是一家主要从事抗体偶联药物（ADC）及其他生物偶联药物的全面合同研究、开发及制造组织（CRDMO）服务的投资控股公司，业务覆盖国内市场、北美、欧洲和世界其他地区。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://wuxixdc.com","stockEarnings":[{"period":"1week","weight":-0.0108},{"period":"1month","weight":-0.1404},{"period":"3month","weight":-0.1531},{"period":"6month","weight":-0.3443},{"period":"1year","weight":0.102},{"period":"ytd","weight":-0.2444}],"compareEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":-0.0531},{"period":"3month","weight":-0.0466},{"period":"6month","weight":-0.0537},{"period":"1year","weight":0.0138},{"period":"ytd","weight":-0.0514}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明合联生物技术有限公司是一家主要从事提供提供抗体偶联药物（ADC）及其他生物偶联药物的全面合同研究、开发及制造组织（CRDMO）服务的投资控股公司。该公司的服务包括生物偶联药物、单克隆抗体中间体及生物偶联药物相关连接子及有效载荷的发现、工艺开发及优良生产质量管理规范（GMP）生产。该公司透过按有偿服务（FFS）基准的合约和按全时当量（FTE）基准的合约向客户提供CRDMO服务。该公司主要在国内市场、北美、欧洲和世界其他地区市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":0.010265},{"month":2,"riseRate":0.666667,"avgChangeRate":0.058284},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.010372},{"month":4,"riseRate":0.555556,"avgChangeRate":0.03555},{"month":5,"riseRate":0.333333,"avgChangeRate":0.006014},{"month":6,"riseRate":0.4,"avgChangeRate":-0.032735},{"month":7,"riseRate":0.4,"avgChangeRate":0.011785},{"month":8,"riseRate":0.4,"avgChangeRate":-0.114063},{"month":9,"riseRate":0.333333,"avgChangeRate":0.019767},{"month":10,"riseRate":0.777778,"avgChangeRate":0.151657},{"month":11,"riseRate":0.333333,"avgChangeRate":0.008796},{"month":12,"riseRate":0.111111,"avgChangeRate":-0.068876}],"exchange":"SEHK","name":"药明合联","nameEN":"WUXI XDC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明合联(02268)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明合联,02268,药明合联股票,药明合联股票老虎,药明合联股票老虎国际,药明合联行情,药明合联股票行情,药明合联股价,药明合联股市,药明合联股票价格,药明合联股票交易,药明合联股票购买,药明合联股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明合联(02268)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}